Orazio Caffo

Summary

Affiliation: S. Maria del Carmine Hospital
Country: Italy

Publications

  1. request reprint
    Caffo O, Lunardi A, Trentin C, Maines F, Veccia A, Galligioni E. Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?. Curr Drug Targets. 2016;17:1301-8 pubmed
    ....
  2. Caffo O, Thompson C, De Santis M, Kragelj B, Hamstra D, Azria D, et al. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. Radiother Oncol. 2016;121:193-198 pubmed publisher
    ..Prospective randomized controlled trials are on-going to definitively assess the efficacy of gemcitabine-based chemoradiotherapy for MIBC. ..
  3. Caffo O, Sava T, Comploj E, Fariello A, Zustovich F, Segati R, et al. Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial. BJU Int. 2008;102:1080-5 pubmed publisher
    ..The patients in arm B had an improvement in pain over time. These data support the existence of a possible advantage in combining docetaxel and EP, which should be verified in a specific randomized phase III study. ..
  4. Maines F, Veccia A, Caffo O. Is it possible that one patient may again experience a response to abiraterone acetate withdrawal during an abiraterone acetate rechallenge?. Eur Urol. 2014;66:179-80 pubmed publisher

Detail Information

Publications4

  1. request reprint
    Caffo O, Lunardi A, Trentin C, Maines F, Veccia A, Galligioni E. Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?. Curr Drug Targets. 2016;17:1301-8 pubmed
    ....
  2. Caffo O, Thompson C, De Santis M, Kragelj B, Hamstra D, Azria D, et al. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. Radiother Oncol. 2016;121:193-198 pubmed publisher
    ..Prospective randomized controlled trials are on-going to definitively assess the efficacy of gemcitabine-based chemoradiotherapy for MIBC. ..
  3. Caffo O, Sava T, Comploj E, Fariello A, Zustovich F, Segati R, et al. Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial. BJU Int. 2008;102:1080-5 pubmed publisher
    ..The patients in arm B had an improvement in pain over time. These data support the existence of a possible advantage in combining docetaxel and EP, which should be verified in a specific randomized phase III study. ..
  4. Maines F, Veccia A, Caffo O. Is it possible that one patient may again experience a response to abiraterone acetate withdrawal during an abiraterone acetate rechallenge?. Eur Urol. 2014;66:179-80 pubmed publisher